Algert Global LLC’s Syndax Pharmaceuticals Inc Position
Does Algert Global LLC own Syndax Pharmaceuticals Inc (SNDX)? Yes — 928.6K shares worth $22M (+0.33% of its 13F portfolio) as of Q1 2026, up from 928.1K shares the prior filed quarter.
Position Value
$22M
Q1 2026
Shares
928.6K
% of Portfolio
+0.33%
Quarters Held
26
currently held
Position History SNDX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 928.6K | $22M | +0.33% |
| Q4 2025 | 928.1K | $19M | +0.30% |
| Q3 2025 | 930.8K | $14M | +0.24% |
| Q2 2025 | 1.02M | $10M | +0.20% |
| Q1 2025 | 884.6K | $11M | +0.27% |
| Q4 2024 | 785.6K | $10M | +0.24% |
| Q3 2024 | 475.0K | $9M | +0.25% |
| Q2 2024 | 432.1K | $9M | +0.30% |
| Q1 2024 | 425.7K | $10M | +0.40% |
| Q4 2023 | 528.2K | $11M | +0.46% |
| Q3 2023 | 456.2K | $7M | +0.31% |
| Q2 2023 | 253.6K | $5M | +0.23% |
| Q1 2023 | 86.0K | $2M | +0.09% |
| Q4 2022 | 77.8K | $2M | +0.11% |
| Q3 2022 | 48.9K | $1M | +0.07% |
| Q2 2022 | 54.7K | $1M | +0.08% |
| Q1 2022 | 41.5K | $722,000 | +0.05% |
| Q4 2021 | 31.6K | $691,000 | +0.09% |
| Q1 2021 | 9.6K | $214,000 | +0.07% |
| Q4 2020 | 27.6K | $613,000 | +0.17% |
| Q3 2020 | 19.1K | $282,000 | +0.09% |
| Q2 2020 | 10.8K | $160,000 | +0.05% |
| Q1 2020 | 22.6K | $248,000 | +0.10% |
| Q4 2019 | 25.6K | $225,000 | +0.07% |
| Q3 2019 | 17.5K | $131,000 | +0.05% |
| Q2 2019 | 15.9K | $148,000 | +0.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Algert Global LLC’s full portfolio or all institutional holders of SNDX.